Chemcon Speciality Chemicals Ltd
₹ 254
1.65%
14 Jun
- close price
About
Chemcon Speciality Chemicals Limited is a manufacturer of specialised chemicals, such as HMDS and CMIC which are predominantly used in the pharmaceuticals industry and inorganic bromides used as completion fluids in the oilfield industry. [1]
Key Points
- Market Cap ₹ 929 Cr.
- Current Price ₹ 254
- High / Low ₹ 319 / 226
- Stock P/E 48.4
- Book Value ₹ 130
- Dividend Yield 1.58 %
- ROCE 5.72 %
- ROE 4.11 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
Cons
- The company has delivered a poor sales growth of -2.51% over past five years.
- Company has a low return on equity of 10.6% over last 3 years.
- Earnings include an other income of Rs.13.2 Cr.
- Dividend payout has been low at 8.86% of profits over last 3 years
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
51 | 53 | 63 | 97 | 88 | 158 | 303 | 262 | 243 | 257 | 303 | 267 | |
46 | 46 | 56 | 87 | 79 | 112 | 237 | 192 | 162 | 175 | 232 | 240 | |
Operating Profit | 5 | 6 | 8 | 10 | 9 | 46 | 66 | 70 | 81 | 82 | 71 | 27 |
OPM % | 10% | 12% | 12% | 10% | 10% | 29% | 22% | 27% | 33% | 32% | 23% | 10% |
0 | 0 | -1 | 0 | 0 | 0 | 2 | 4 | 5 | 9 | 13 | 13 | |
Interest | 2 | 2 | 2 | 3 | 2 | 3 | 4 | 5 | 4 | 1 | 1 | 4 |
Depreciation | 1 | 1 | 2 | 2 | 2 | 2 | 3 | 5 | 6 | 6 | 8 | 10 |
Profit before tax | 3 | 3 | 3 | 5 | 5 | 41 | 61 | 65 | 76 | 84 | 74 | 26 |
Tax % | 33% | 60% | 3% | 35% | 37% | 35% | 30% | 25% | 26% | 25% | 26% | 27% |
2 | 1 | 3 | 3 | 3 | 26 | 43 | 49 | 56 | 63 | 55 | 19 | |
EPS in Rs | 2.11 | 1.46 | 3.35 | 4.09 | 3.78 | 33.21 | 13.54 | 15.37 | 15.40 | 17.13 | 15.04 | 5.24 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 27% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | 18% |
5 Years: | -3% |
3 Years: | 3% |
TTM: | -12% |
Compounded Profit Growth | |
---|---|
10 Years: | 32% |
5 Years: | -15% |
3 Years: | -30% |
TTM: | -65% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | -18% |
1 Year: | -8% |
Return on Equity | |
---|---|
10 Years: | 17% |
5 Years: | 15% |
3 Years: | 11% |
Last Year: | 4% |
Balance Sheet
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 8 | 8 | 8 | 8 | 8 | 8 | 32 | 32 | 37 | 37 | 37 | 37 |
Reserves | 10 | 11 | 13 | 16 | 19 | 46 | 65 | 115 | 317 | 381 | 421 | 440 |
13 | 14 | 12 | 13 | 20 | 17 | 33 | 46 | 6 | 36 | 64 | 43 | |
6 | 12 | 10 | 9 | 15 | 27 | 43 | 34 | 44 | 45 | 32 | 26 | |
Total Liabilities | 37 | 45 | 44 | 46 | 63 | 97 | 173 | 226 | 404 | 498 | 553 | 545 |
14 | 20 | 20 | 19 | 24 | 30 | 40 | 49 | 67 | 82 | 141 | 146 | |
CWIP | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 4 | 9 | 34 | 14 | 42 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
22 | 25 | 24 | 27 | 38 | 67 | 133 | 173 | 328 | 382 | 398 | 356 | |
Total Assets | 37 | 45 | 44 | 46 | 63 | 97 | 173 | 226 | 404 | 498 | 553 | 545 |
Cash Flows
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
3 | 7 | 5 | 10 | 14 | 11 | 12 | 65 | 74 | 13 | 12 | ||
-4 | -5 | -2 | -9 | -7 | -24 | -16 | -152 | -92 | -16 | -25 | ||
0 | -3 | -3 | -2 | -6 | 12 | 4 | 111 | 30 | 12 | -25 | ||
Net Cash Flow | -0 | -1 | -0 | -1 | 1 | -0 | 0 | 23 | 11 | 9 | -37 |
Ratios
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 51 | 40 | 52 | 51 | 93 | 68 | 77 | 124 | 142 | 146 | 81 | 112 |
Inventory Days | 107 | 146 | 74 | 45 | 58 | 99 | 91 | 118 | 175 | 102 | 164 | 119 |
Days Payable | 46 | 97 | 79 | 39 | 81 | 82 | 57 | 63 | 67 | 70 | 44 | 23 |
Cash Conversion Cycle | 112 | 89 | 47 | 57 | 70 | 86 | 111 | 179 | 250 | 177 | 201 | 208 |
Working Capital Days | 118 | 85 | 64 | 59 | 79 | 93 | 95 | 175 | 189 | 155 | 184 | 220 |
ROCE % | 17% | 17% | 17% | 22% | 16% | 74% | 65% | 43% | 29% | 21% | 15% |
Documents
Announcements
- Compliances-Reg.24(A)-Annual Secretarial Compliance 25 May
- Announcement under Regulation 30 (LODR)-Investor Presentation 20 May
- Announcement under Regulation 30 (LODR)-Newspaper Publication 20 May
- Comments Made By The Board On The Notice For Non-Compliance With SEBI (LODR) Regulations, 2015 Issued By National Stock Exchange Of India Limited And BSE Limited 18 May
- The Audited Financial Results For The Quarter And Financial Year Ended March 31, 2024. 18 May
Annual reports
Concalls
-
May 2024TranscriptNotesPPT
-
Feb 2024TranscriptNotesPPT
-
Nov 2023Transcript PPT
-
Aug 2023TranscriptNotesPPT
-
May 2023TranscriptNotesPPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022TranscriptNotesPPT
-
Jun 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Nov 2021Transcript PPT
-
Aug 2021Transcript PPT
-
Jun 2021Transcript PPT
-
Feb 2021Transcript PPT
-
Dec 2020Transcript PPT
Products Portfolio
Organic Chemicals (55% in 9MFY24 vs 59% in FY19)- Hexamethyl Disilazane (HMDS), Chloromethyl Isopropyl Carbonate (CMIC) both used in pharma, and Bromobenzene used in Agrochemicals.